Barcelona, Spain: Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients, according to research presented at the ESTRO 37 conference. The treatment, called ultrahypofractionated radiotherapy, involves hospital treatment every other day for two and half weeks, compared to every week day for eight weeks for […]
April 2018
Targeted radiotherapy for breast cancer offers good quality of life and fewer side effects
Barcelona, Spain: Quality of life for women treated with a more targeted radiotherapy treatment – called accelerated partial breast irradiation – is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology. The treatment uses […]
Correcting tiny differences in patient’s position for radiotherapy could increase survival chances
Barcelona, Spain: Very small differences in the way a patient lies during radiotherapy treatment for lung or oesophageal cancer can have an impact on how likely they are to survive, according to research presented at the ESTRO 37 conference. These differences of only a few millimetres can mean that the radiation treatment designed to target […]
Brachytherapy for cervical cancer patients does not increase the risk of ureteral stricture
Barcelona, Spain: A rare but potentially serious complication following radiation treatment for cervical cancer is a narrowing of the tube (the ureter) that takes urine from the kidneys to the bladder, which can lead to kidney damage and sometimes life-threatening infections. This is called ureteral stricture and, until now, there have been concerns that brachytherapy […]
Elderly non-small cell lung cancer patients are less likely to benefit from treatment with simultaneous radio- and chemotherapy
Barcelona, Spain: An analysis of elderly patients treated in a phase II trial of radiotherapy combined with chemotherapy in non-small cell lung cancer (NSCLC) has shown that they were less likely to benefit than younger patients if the two treatments were given at the same time. Previous research has shown that for NSCLC patients with […]
Handgrip strength test is a good indicator of survival in non-small cell lung cancer patients
Barcelona, Spain: A simple test of handgrip strength is a good indicator of short- and long-term survival in patients with early, stage I non-small cell lung cancer (NSCLC), according to new findings presented at the European Society for Radiotherapy and Oncology (ESTRO 37) conference [1]. In a study of 226 patients who were about to […]